|Day's Range||5.74 - 5.74|
Throughout this month, U.S. stock markets are witnessing extreme volatility. Equities are suffering as investors are flocking to safe-haven sovereign bonds.
executive vice president & CFO of Chemed Corp (30-Year Financial, Insider Trades) David Patrick Williams (insider trades) sold 17,979 shares of CHE on 08/12/2019 at an average price of $430.8 a share. Continue reading...
president and CEO of Chemed Corp (30-Year Financial, Insider Trades) Kevin J Mcnamara (insider trades) sold 12,000 shares of CHE on 08/07/2019 at an average price of $416.8 a share. Continue reading...
The VITAS and Chemed updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS on July 31, 2019, and effective October 1, 2019. This updated guidance also includes certain increased costs related to revenue pass-through under certain inpatient unit agreements.
Roto-Rooter Services Company, a wholly-owned subsidiary of Chemed Corporation announced it has entered into an agreement to acquire all of HSW RR, Inc.’s franchise operations and Western Drain Supply for an aggregate purchase price of $120 million.
Chemed Corporation (CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 32-cents per share on the Company’s capital stock, payable on September 3, 2019, to shareholders of record as of August 12, 2019. The previous dividend increase was in August 2018, when the Board raised the quarterly dividend from 28-cents to 30-cents per share. This represents the 193rd consecutive quarterly dividend paid by Chemed in its 48 years as a public company.
Since existence of a debt-free company is rare, the real challenge for an investor is determining whether an organization???s debt level is sustainable.
Chemed (CHE) delivered earnings and revenue surprises of 8.74% and 0.80%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Chemed Corporation , which operates VITAS Healthcare Corporation , one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.